Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Post by Edp007on Jul 06, 2016 8:12pm

126 Views

Post# 25029795

Makena Resources acquisition of DB Diamond

2016-07-06 19:39 ET - Acquisition

The TSX Venture Exchange has accepted for filing a share purchase agreement dated June 28, 2016, between Makena Resources Inc., and Graeme Sewell, MGK Consulting Inc. and Munir Ali, whereby the company may acquire 100 per cent of the shares of DB Diamond Holdings Inc., which holds one claim covering 4,060 hectares in the Athabasca region of Saskatchewan. Consideration is 15,999,999 shares.

https://www.stockwatch.com/News/Item.aspx?bid=Z-C:MKN-2388002&symbol=MKN&region=C

Bullboard Posts

How one company is disrupting PoC testing